These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 444916)

  • 1. Continuous subcutaneous neostigmine in the management of severe myasthenia gravis.
    Bingle JP; Rutherford JD; Woodrow P
    Br Med J; 1979 Apr; 1(6170):1050. PubMed ID: 444916
    [No Abstract]   [Full Text] [Related]  

  • 2. Administering Neostigmine as a Subcutaneous Infusion: A Case Report of a Patient Dying With Myasthenia Gravis.
    Hindmarsh J; Woods E; Lee M; Pickard J
    J Palliat Care; 2020 Apr; 35(2):78-81. PubMed ID: 31411109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute treatment of myasthenia gravis with intranasal neostigmine: clinical and electromyographic evaluation.
    Ricciardi R; Rossi B; Nicora M; Sghirlanzoni A; Muratorio A
    J Neurol Neurosurg Psychiatry; 1991 Dec; 54(12):1061-2. PubMed ID: 1783916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral neostigmine and lymphatic absorption in a myasthenia gravis patient on continuous ambulatory peritoneal dialysis (CAPD).
    Chan PC; Tam SC; Cheng IK
    Perit Dial Int; 1990; 10(1):93-6. PubMed ID: 2085592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neostigmine-responsive weakness in the dog, similar to myasthenia gravis.
    Lorenz MD; DeLahunta A; Alstrom DH
    J Am Vet Med Assoc; 1972 Oct; 161(7):795-800. PubMed ID: 5074261
    [No Abstract]   [Full Text] [Related]  

  • 6. Continuous neostigmine infusion in post-thymectomy juvenile myasthenic crisis.
    Briassoulis G; Hatzis T; Liakopoulou T; Youroukos S
    J Child Neurol; 2000 Nov; 15(11):747-9. PubMed ID: 11108508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal versus intravenous neostigmine in myasthenia gravis: assessment by computer analysis of saccadic eye movements.
    Di Costanzo A; Toriello A; Mannara C; Benvenuti C; Tedeschi G
    Clin Neuropharmacol; 1993 Dec; 16(6):511-7. PubMed ID: 9377586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of corticosteroids in a dog with myasthenia gravis.
    Van Heerden J; Van Schouwenburg SJ
    J S Afr Vet Assoc; 1983 Jun; 54(2):135-7. PubMed ID: 6631903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of neostigmine on the electromyographic record in myasthenia].
    Wochnik-Dyjas D; Niewiadomska M
    Neurol Neurochir Pol; 1970; 4(1):7-13. PubMed ID: 5439405
    [No Abstract]   [Full Text] [Related]  

  • 10. Myasthenia gravis.
    Balakrishnan S; Paul H
    J Indian Med Assoc; 1967 Aug; 49(3):140-2. PubMed ID: 6079093
    [No Abstract]   [Full Text] [Related]  

  • 11. Coexisting childhood schizophrenia and myasthenia gravis treated successfully with neostigmine bromide.
    Schnackenberg RC; Holmes G
    Am J Psychiatry; 1977 Sep; 134(9):1025-7. PubMed ID: 900286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myasthenia gravis in children.
    Markam S; Sic PEK GIOK ; Mardjono M
    Paediatr Indones; 1965; 5(1-2):19-23. PubMed ID: 5874171
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapetic measures in myasthenia gravis].
    Cavaciuti P; Gatti E
    Minerva Anestesiol; 1969 Aug; 35(8):765-79. PubMed ID: 5364124
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of intranasal administration of neostigmine in myasthenic patients.
    Sghirlanzoni A; Pareyson D; Benvenuti C; Cei G; Cosi V; Lombardi M; Nicora M; Ricciardi R; Cornelio F
    J Neurol; 1992 Mar; 239(3):165-9. PubMed ID: 1573422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacology of pyridostigmine and neostigmine in patients with myasthenia gravis.
    Aquilonius SM; Eckernäs SA; Hartvig P; Lindström B; Osterman PO; Stålberg E
    J Neurol Neurosurg Psychiatry; 1983 Oct; 46(10):929-35. PubMed ID: 6644317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Triaminopteridine in the therapy of myasthenia gravis].
    Mansoldo G; Battocchia A; De Candia O
    Minerva Med; 1968 Apr; 59(33):1936-9. PubMed ID: 5653968
    [No Abstract]   [Full Text] [Related]  

  • 17. Teaching neuroimages: reversible ectropion in myasthenia gravis.
    Chang GY; Solé G; Ferrer X
    Neurology; 2010 Apr; 74(15):1239; author reply 1239. PubMed ID: 20385900
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of severe forms of myasthenia with prednisolone and triamcinolone].
    Gekht VM; Kuzin MI; Kuralsein MG; Shagal DI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(6):815-9. PubMed ID: 1217381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myasthenia gravis and glycopyrrolate.
    Marcus E; Wayne F
    S Afr Med J; 1981 Oct; 60(17):650. PubMed ID: 7302713
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current treatment of myasthenia gravis].
    de Assis JL
    Rev Paul Med; 1965 Oct; 67(4):231-42. PubMed ID: 5848156
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.